Log in to save to my catalogue

Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Aci...

Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Aci...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b12b6961514347afbfb91b629321616d

Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Acid in Topical Formulations: In Vitro Cytotoxicity and Drug Release Studies

About this item

Full title

Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Acid in Topical Formulations: In Vitro Cytotoxicity and Drug Release Studies

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2019-05, Vol.24 (9), p.1820

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Salicylic acid (SA) has for a long time been used to treat various skin disorders due to its anti-inflammatory, bacteriostatic, and antifungal properties. In the present work, mesoporous magnesium carbonate (MMC), a promising drug carrier, was modified with 3-aminopropyl-triethoxysilane to enable loading of SA. The amine modified MMC (aMMC) was suc...

Alternative Titles

Full title

Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Acid in Topical Formulations: In Vitro Cytotoxicity and Drug Release Studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b12b6961514347afbfb91b629321616d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b12b6961514347afbfb91b629321616d

Other Identifiers

ISSN

1420-3049,1431-5157

E-ISSN

1420-3049

DOI

10.3390/molecules24091820

How to access this item